Autosomal Dominant Intermediate Charcot-Marie-Tooth Disease Type F (CMTDIF)

Autosomal dominant intermediate Charcot-Marie-Tooth disease type F (CMTDIF) is a very rare inherited nerve disease that affects the long nerves to the feet, legs, hands, and arms. It causes slowly worsening weakness and muscle loss in the hands and feet, loss of feeling, reduced reflexes, and foot deformities such as high arches or hammertoes.Genetic Diseases Center+1 This condition is called “intermediate” because nerve conduction tests show speeds between those seen in demyelinating CMT (very slow) and axonal CMT (near normal), meaning both the myelin covering of the nerves and the nerve fibers themselves are damaged.PubMed+1 The word “autosomal dominant” means that a change in only one copy of the gene is enough to cause the disease, and an affected parent has a 50% chance of passing it to each child.MedlinePlus+1

Autosomal dominant intermediate Charcot-Marie-Tooth disease type F (often shortened to CMTDIF) is a very rare inherited nerve disease. It affects the long nerves that carry signals to the muscles and bring feeling back from the feet and hands. Because the nerve damage is both “demyelinating” (damage to the myelin coating) and “axonal” (damage to the nerve fiber itself), it is called an “intermediate” form of CMT. Orpha.net+1

The disease is autosomal dominant. This means a person can get the condition if they inherit just one copy of the changed gene from either parent. Each child of an affected parent has a 50% chance of inheriting the mutation. Men and women are affected equally. NCBI+1

In CMTDIF, the main known cause is a change (mutation) in one copy of the GNB4 gene, which sits on chromosome 3q26–3q28 and makes a protein called Gβ4. This protein is part of G-protein–coupled receptor (GPCR) signaling in nerve cells and Schwann cells. When GNB4 is mutated, signaling is disturbed and peripheral nerves slowly stop working normally.ZFIN+2Mouse Genome Informatics+2

People with autosomal dominant intermediate CMT type F usually develop symptoms from childhood to mid-adult life, and symptoms progress slowly over many years. Most people remain able to walk but may need ankle–foot braces or other aids later in life.Genetic Diseases Center+1

---

Other names

This condition is known by several medical names that all mean almost the same thing. Different databases and research papers may use different labels:

1. Autosomal dominant intermediate Charcot-Marie-Tooth disease type F – the full formal name that stresses inheritance (autosomal dominant), the “intermediate” nerve conduction speed, and subtype F.Orpha.net+1

2. Charcot-Marie-Tooth disease, dominant intermediate F – a shorter form used in rare-disease and genetic databases.NCBI+1

3. CMTDIF – the standard abbreviation used in research papers, where “CMT” means Charcot-Marie-Tooth, “DI” means dominant intermediate, and “F” is the subtype letter.ZFIN+1

4. Autosomal dominant intermediate CMT type F – another way to say that the disease belongs to the autosomal dominant intermediate group of CMT and is the F subtype.Disease Ontology+1

5. Hereditary motor and sensory neuropathy, dominant intermediate type F – some older sources use “hereditary motor and sensory neuropathy (HMSN)” instead of CMT, but they describe the same group of diseases.Wikipedia+1

---

Types

Charcot-Marie-Tooth disease as a whole has many types based on nerve conduction speed, the main place of damage (myelin or axon), and the inheritance pattern. CMTDIF belongs to the “intermediate” and “dominant intermediate” groups:PubMed+1

1. Main CMT categories – CMT1 (demyelinating), CMT2 (axonal), CMT4 (autosomal recessive), CMTX (X-linked), and intermediate CMT, where nerve conduction speed falls between typical demyelinating and axonal ranges.Wikipedia+1

2. Intermediate CMT – in this group, median motor nerve conduction velocity is usually between about 25 and 45 m/s. Patients show a mix of myelin damage and axonal loss on tests and nerve biopsy.PubMed+1

3. Dominant intermediate CMT (CMT-DI) – this subgroup includes people whose disease is intermediate by nerve conduction and autosomal dominant by inheritance. There are several genetic subtypes named with letters A to F.Charcot-Marie-Tooth Association+1

4. CMTDIA, CMTDIB, CMTDIC, CMTDID, CMTDIE, CMTDIF – these six subtypes of dominant intermediate CMT are defined by different genes and chromosome positions; subtype F (CMTDIF) is the one linked to mutations in GNB4.Wikipedia+1

5. CMTDIF (GNB4-related) – this specific type is an intermediate CMT with autosomal dominant inheritance and a proven cause in heterozygous (single-copy) pathogenic mutations in the GNB4 gene, usually missense variants that change one amino acid in the protein.ZFIN+2Mouse Genome Informatics+2

In daily clinical practice, doctors may simply tell patients they have “Charcot-Marie-Tooth disease due to a GNB4 mutation” rather than using the full code CMTDIF.Mayo Clinic+1

---

Causes

For this disease, the main and direct cause is a mutation in one copy of the GNB4 gene. The 20 “causes” below describe different scientific aspects of this same core genetic problem and factors that can influence how it shows up, not 20 separate unrelated triggers:ZFIN+2Mouse Genome Informatics+2

1. Pathogenic GNB4 missense mutations
   Most people with CMTDIF have a missense mutation in GNB4, where one DNA letter changes and swaps one amino acid in the Gβ4 protein. This change harms the protein’s shape and function and leads to chronic damage of peripheral nerves.PubMed+1

2. Defective G-protein β-subunit (Gβ4) function
   GNB4 encodes Gβ4, part of the G-protein complex that carries signals from cell-surface receptors to the inside of nerve cells and Schwann cells. Mutations reduce normal Gβ4 function, so important survival and repair signals in peripheral nerves are weakened.PubMed+1

3. Impaired GPCR signaling in peripheral nerves
   Studies show that mutant Gβ4 proteins disturb bradykinin-induced G-protein–coupled receptor signaling, which is one example of how nerve cells use GPCRs. This signaling failure slowly damages axons and myelin, contributing to intermediate CMT.PubMed+1

4. Loss of Gβ4 in Schwann cells
   In nerve biopsies from affected people, Gβ4 protein is strongly reduced in Schwann cells, the cells that make myelin around peripheral nerves. Without normal Gβ4, Schwann cells cannot fully support or protect nerve fibers.PubMed+1

5. Loss of Gβ4 in axons
   Gβ4 is also present in the axons themselves. When GNB4 mutations lower Gβ4 levels in axons, the nerve fibers become more vulnerable to stress, gradually leading to axonal degeneration and muscle weakness.PubMed+1

6. Mixed demyelinating and axonal injury
   Because GNB4 is needed in both Schwann cells and axons, its mutation causes both myelin damage and axonal loss. This mixed pattern explains why nerve conduction speeds in CMTDIF are intermediate instead of purely demyelinating or purely axonal.PubMed+1

7. Autosomal dominant inheritance pattern
   The disease is autosomal dominant: one mutated GNB4 copy plus one normal copy are enough to cause disease. Each child of an affected person has about a 50% chance to inherit the mutation and develop CMTDIF.MedlinePlus+1

8. De novo (new) GNB4 mutations
   Some cases appear in families with no previous history because a new (de novo) GNB4 mutation happens in the egg or sperm, so the affected person is the first in the family to have the disease.PubMed+1

9. Allelic heterogeneity (different mutations in the same gene)
   Different disease-causing changes (variants) in GNB4 can all lead to CMTDIF. Some variants may cause earlier onset or more severe weakness, but all disturb Gβ4 and GPCR signaling.MalaCards+1

10. Interaction with other CMT genes (genetic background)
    People with CMTDIF still carry many other genes that affect nerve health. Variants in other CMT-related genes might modify disease severity, even though they are not the primary cause.Wikipedia+1

11. Length-dependent nerve vulnerability
    Long nerves to the feet and hands are more sensitive to any impairment in axonal transport or signaling. This is why symptoms start distally (in the feet) even though the genetic change is present in all nerve cells.Wikipedia+1

12. Chronic failure of axonal transport
    GPCR signaling problems and structural damage may disturb movement of nutrients and cell parts along the axon, causing a slow “dying-back” of distal nerve fibers and contributing to weakness and sensory loss.PubMed+1

13. Secondary demyelination due to axonal dysfunction
    When axons are unhealthy, Schwann cells cannot maintain normal myelin, leading to secondary demyelination. This also lowers nerve conduction velocity and increases disability.PubMed+1

14. Secondary axonal loss due to myelin damage
    The reverse is also true: when myelin is damaged first, axons may later degenerate. In CMTDIF, this two-way damage cycle helps explain long-term progression.PubMed+1

15. Age-related cumulative damage
    Because nerve repair is limited, even a small constant defect in signaling and structure can build up over years, causing more weakness and disability with age.Mayo Clinic+1

16. Possible environmental stress on already fragile nerves
    Although environment does not cause CMTDIF by itself, factors like chronic nerve compression, repeated ankle injuries, or very poor footwear may worsen weakness or deformities in someone whose nerves are already fragile from GNB4 mutation.Mayo Clinic+1

17. Metabolic stress from other illnesses
    Illnesses like poorly controlled diabetes, severe vitamin deficiencies, or thyroid disease can worsen any peripheral neuropathy, including CMTDIF, even though they are not the primary genetic cause. Doctors usually try to correct these to protect nerves.Mayo Clinic+1

18. Lifestyle-related reduced muscle strength
    Low physical activity and long periods of immobility do not cause the gene defect, but they can lead to extra muscle loss and joint stiffness on top of the underlying neuropathy, making symptoms look worse.Mayo Clinic+1

19. Mechanical foot problems due to weak muscles
    Weak ankle and foot muscles lead to abnormal walking patterns and high-arched feet. Over time, these mechanical stresses can cause tendon shortening and joint deformities, further limiting movement.Genetic Diseases Center+1

20. Psychological and social factors
    Long-term disability, fatigue, and visible deformities can contribute to anxiety, low mood, or social withdrawal, which may reduce activity and rehabilitation efforts. This does not cause the neuropathy, but it may affect how strongly the disease impacts daily life.Mayo Clinic+1

---

Symptoms

The main symptoms of autosomal dominant intermediate CMT type F are similar to other forms of CMT, but severity and age of onset can vary between families and even between people in the same family.Genetic Diseases Center+2Mayo Clinic+2

1. Slowly progressive distal leg weakness
   The earliest sign is often weakness in the muscles around the ankles and feet. People may notice tripping, difficulty running, or trouble standing on their toes. This weakness usually develops slowly over many years.Genetic Diseases Center+1

2. Foot drop and steppage gait
   Because the muscles that lift the front of the foot become weak, the toes drag on the floor. To avoid tripping, people may lift their knees higher when walking, called a steppage gait.Mayo Clinic+1

3. Muscle wasting in the lower legs (“stork legs”)
   Over time the muscles in the calves shrink, giving the lower legs a thin, “stork-like” appearance. The skin may look loose over the wasted muscles.Genetic Diseases Center+1

4. Distal sensory loss in feet and hands
   Many people lose some feeling in their toes and feet and later in their fingers. They may have reduced sensitivity to vibration, light touch, pain, or temperature. This can make injuries harder to notice.Genetic Diseases Center+1

5. Numbness and tingling (paresthesias)
   Some people feel tingling, burning, or “pins and needles” in the feet or hands. These abnormal sensations are due to damaged sensory fibers in the peripheral nerves.Mayo Clinic+1

6. Hand weakness and fine motor problems
   As the disease progresses, weakness can affect the small muscles of the hands. People may have difficulty doing up buttons, writing, typing, or opening jars.Genetic Diseases Center+1

7. Reduced or absent deep tendon reflexes
   Reflexes at the ankles and knees are often weak or absent when checked with a reflex hammer. This is a common neurological sign of peripheral neuropathy in CMT.Genetic Diseases Center+1

8. Foot deformities (pes cavus, hammertoes)
   High-arched feet (pes cavus), clawed toes, or hammertoes are very common. Unequal pulling of weak and strong muscles slowly bends the joints into abnormal positions.Genetic Diseases Center+1

9. Poor balance and frequent falls
   Weak ankle muscles and loss of joint position sense (proprioception) make it harder to keep balance, especially in the dark or on uneven ground. Falls and near-falls may become more frequent.Mayo Clinic+1

10. Fatigue during walking or standing
    Because the leg muscles are weak and the gait is inefficient, walking and standing take more effort. People often feel tired after short distances and may need frequent rests.Mayo Clinic+1

11. Neuropathic pain in some patients
    Not everyone has pain, but some people feel burning or shooting pains in the feet or legs. This is called neuropathic pain and comes from damaged sensory nerves sending abnormal signals.Mayo Clinic+1

12. Cramps and muscle spasms
    Calf or foot muscle cramps can occur, especially after activity or at night. These painful contractions reflect instability in motor units and irritated motor nerves.Mayo Clinic+1

13. Mild scoliosis or posture changes
    Some people develop mild curvature of the spine or poor posture as they adapt their body to muscle weakness and foot deformities. This is more common in childhood-onset CMT.Mayo Clinic+1

14. Difficulty with hand-based tasks and handwriting
    When hand muscles weaken, writing can become messy and slow, and tasks like sewing, using tools, or playing instruments may be harder. Children may struggle with school tasks that require fine hand control.Wiley Online Library+1

15. Emotional impact and reduced quality of life
    Living with a visible, progressive nerve disease may cause worry, sadness, or frustration, especially in young people. This emotional burden can affect school, work, and social life, even though it does not change the nerve damage itself.Mayo Clinic+1

---

Diagnostic tests

Doctors diagnose autosomal dominant intermediate CMT type F by combining the story of symptoms, a detailed neurological examination, nerve conduction and EMG tests, and finally genetic testing for GNB4. Many other tests are used to confirm the pattern and rule out other causes of neuropathy.ResearchGate+2PubMed+2

Physical examination tests

1. General neurological examination
   The neurologist looks for muscle weakness, wasting, changes in tone, abnormal movements, and sensory loss. The pattern of weakness (distal more than proximal, legs before arms) and symmetrical findings strongly suggest a hereditary neuropathy like CMT.Mayo Clinic+1

2. Gait observation
   The doctor watches how the person walks, looking for foot drop, steppage gait, imbalance, and difficulty walking on heels or toes. A high-stepping gait with frequent tripping is a classic sign of distal leg weakness in CMT.Mayo Clinic+1

3. Foot and ankle inspection
   The examiner checks for high arches, flat feet, hammertoes, calluses, and ankle instability. Characteristic foot deformities together with neuropathy signs strongly support a diagnosis of CMT rather than an acquired neuropathy.Genetic Diseases Center+1

4. Muscle strength grading
   Using manual muscle testing, the doctor grades strength in ankles, knees, hips, wrists, and fingers on a standard scale (for example the MRC scale). Distal muscle groups, especially ankle dorsiflexors and toe extensors, are usually the weakest in CMTDIF.PFM Journal+1

5. Reflex and sensory examination
   Deep tendon reflexes (ankle, knee, biceps) are tested with a hammer and are often reduced or absent. Sensation to vibration, touch, pain, and temperature is tested with simple tools to map areas of sensory loss in hands and feet.Genetic Diseases Center+1

Manual (bedside) tests

6. Heel-to-toe walking test
   The person is asked to walk in a straight line placing heel to toe. People with CMTDIF may sway, step wide, or be unable to perform this because of weak ankles and poor balance, showing functional impact of the neuropathy.Mayo Clinic+1

7. Romberg balance test
   Standing with feet together, first with eyes open and then closed, helps assess proprioception (joint position sense). Increased swaying or falls with eyes closed suggest sensory neuropathy affecting the long nerves to the legs.Wiley Online Library+1

8. Vibration tuning-fork test
   A vibrating tuning fork is placed on the big toe and ankle bones to see how long the vibration is felt. In CMTDIF, vibration sense is often reduced or lost at the toes, supporting the diagnosis of a length-dependent sensory neuropathy.Mayo Clinic+1

9. Hand function tests
   Simple bedside tasks like buttoning, writing, picking up small objects, or measuring grip strength can show weakness and loss of fine motor control in the hands, which is common in more advanced CMT.Wiley Online Library+1

Laboratory and pathological tests

10. Routine blood tests to exclude other neuropathies
    Blood tests for glucose, vitamin B12, thyroid function, kidney and liver function, and some autoantibodies help rule out diabetes, vitamin deficiency, thyroid disease, and immune neuropathies, which can mimic or worsen CMT symptoms.Mayo Clinic+1

11. Single-gene GNB4 testing
    If the clinical picture suggests intermediate autosomal dominant CMT and nerve conduction is intermediate, DNA testing for GNB4 mutations can confirm CMTDIF when a known pathogenic variant is found.ZFIN+1

12. Multigene CMT panel testing
    Many centers use next-generation sequencing panels that include many CMT genes (such as PMP22, MPZ, MFN2, GJB1, and GNB4). This is efficient because there are over 100 CMT-related genes and several intermediate dominant subtypes.ResearchGate+2www.elsevier.com+2

13. Whole-exome sequencing in unclear cases
    When panel testing is negative but CMT is still suspected, exome sequencing can search through all coding genes. This method was how GNB4 mutations were first discovered as a cause of dominant intermediate CMT.PubMed+1

14. Nerve biopsy (usually sural nerve)
    In special situations, a small piece of sensory nerve (often the sural nerve near the ankle) is removed and examined under the microscope. In intermediate CMT, both demyelinating features (onion bulbs, segmental demyelination) and axonal loss can be seen.Genetic Diseases Center+1

15. Pathology study of the nerve biopsy
    Pathologists use light and electron microscopy to look at myelin thickness, axon density, and signs of regeneration. Finding mixed demyelinating and axonal changes supports an intermediate CMT diagnosis rather than pure CMT1 or CMT2.PubMed+1

Electrodiagnostic tests

16. Motor nerve conduction studies (NCS)
    Electrodes stimulate motor nerves (for example peroneal or tibial nerves) and measure how fast and how strongly signals travel. In CMTDIF, conduction velocities are intermediate (around 25–45 m/s), and compound muscle action potentials may be reduced.PubMed+1

17. Sensory nerve conduction studies
    Sensory responses from nerves like the sural nerve are measured. In intermediate CMT, sensory action potentials are often reduced or absent, showing sensory fiber damage in addition to motor neuropathy.PubMed+1

18. Needle electromyography (EMG)
    A fine needle electrode is inserted into muscles to record electrical activity at rest and during contraction. EMG in CMT shows signs of chronic denervation and reinnervation, confirming that weakness is due to peripheral nerve disease, not primary muscle disease.ResearchGate+1

Imaging tests

19. Foot and ankle X-rays
    Plain X-rays can show bony changes due to long-standing deformities, such as high arches, hammertoes, and joint misalignment. This helps orthopedic planning for braces or surgery but does not show the nerves themselves.Mayo Clinic+1

20. MRI or ultrasound of peripheral nerves and spine
    MRI neurography or nerve ultrasound can show thickened nerves in some CMT types, though findings may be subtle. Spine or brain MRI is often normal, but it is useful to exclude other causes like spinal cord disease or structural lesions that might mimic neuropathy.PubMed+1

Non-pharmacological treatments (therapies and other approaches)

1. Physiotherapy (physical therapy)
   Physiotherapy is one of the most important non-drug treatments for CMT. A trained therapist teaches safe stretching, strengthening, and balance exercises. The goal is to keep muscles flexible, slow down contractures (muscles becoming stiff and short), and maintain walking ability for as long as possible. Regular, gentle exercise can also reduce fatigue and improve mood. Programs are usually low-impact, such as walking in water, cycling, or light resistance work, and are adjusted to the person’s strength and balance. nhs.uk+2Physiopedia+2

2. Occupational therapy
   Occupational therapists focus on the “activities of daily living”, like dressing, writing, using a phone, or working at a computer. They suggest special tools (adaptive devices), teach energy-saving strategies, and adjust the home or workplace to make tasks safer and easier. For example, they may recommend built-up handles, voice-activated devices, or different keyboard layouts. This helps people with CMTDIF stay independent at school, work, and home. Charcot-Marie-Tooth Association+1

3. Ankle-foot orthoses (AFOs) and braces
   Because many people with CMT have “foot drop” (difficulty lifting the front of the foot), braces such as AFOs can help keep the ankle and foot in a better position. This reduces tripping, improves walking pattern, and decreases the risk of falls. Orthotic devices are custom-made by a specialist after careful assessment of muscle strength and joint movement. They need to be checked regularly as the disease and the body change. ScienceDirect+2PMC+2

4. Custom shoe inserts and footwear
   Podiatrists and orthotists often prescribe foot orthoses (insoles) and supportive shoes. High arches and hammer toes can cause pain and pressure points. Proper insoles spread the weight more evenly and improve foot alignment. Soft, wide, supportive shoes with good grip reduce falls and make walking less tiring. PMC+1

5. Stretching and contracture prevention
   Daily stretching of the calves, hamstrings, hip muscles, and hand muscles can slow the development of joint contractures. Contractures make joints stiff and difficult to move, which worsens walking and hand use. A therapist teaches gentle stretches that can be done at home, often holding each stretch for 20–30 seconds and repeating several times. Consistency is more important than intensity. nhs.uk+1

6. Balance and fall-prevention training
   Because nerve damage affects balance, people with CMTDIF are at high risk of falling. Balance training includes simple exercises such as standing on one leg while holding a support, stepping between markers, or walking on soft surfaces in a safe environment. Therapists also teach how to safely get up from a fall and how to arrange furniture and lighting to reduce hazards at home. Physiopedia+1

7. Gentle aerobic exercise
   Low-impact aerobic exercise such as walking, swimming, or cycling can improve heart and lung health, reduce fatigue, and support mental health. The intensity is usually low to moderate, with rest breaks as needed. Over-exertion can increase pain and fatigue, so programs are carefully paced. Exercise is usually safer when supervised at first by a physiotherapist familiar with CMT. Physiopedia+1

8. Hand therapy and fine motor training
   As hand weakness appears, hand therapy helps maintain grip and finger control. Exercises may use putty, rubber bands, or everyday tasks like buttoning and handwriting. Splints can support weak thumbs or wrists. Training helps people keep skills for writing, using a phone, or doing hobbies, which supports independence and quality of life. Physiopedia+1

9. Pain psychology and cognitive-behavioural therapy (CBT)
   Chronic neuropathic pain can affect sleep, mood, and stress levels. Pain psychology or CBT teaches ways to cope with persistent pain, such as relaxation, breathing techniques, and changing unhelpful thought patterns. This does not say “pain is in the mind”; rather, it uses brain-based tools to reduce suffering and improve daily functioning alongside medical treatment. Muscular Dystrophy Association+1

10. Education and self-management training
    Understanding the disease helps people make safer choices. Education covers topics like foot care, safe activity levels, avoiding nerve-toxic medicines, and recognizing signs of rapid worsening. CMT foundations and support groups provide written guides and online resources that are based on expert consensus and studies. Charcot-Marie-Tooth Association+2Charcot-Marie-Tooth Association+2

11. Assistive devices for mobility
    Canes, trekking poles, crutches, or walkers can improve stability and allow longer distances with less fatigue. Choosing the right device depends on muscle strength and balance. A therapist checks height, hand grip, and walking pattern to reduce strain on shoulders and wrists. Using aids is a sign of active self-care, not weakness. Muscular Dystrophy Association+1

12. Wheelchairs and scooters for long distances
    Some people with CMTDIF will eventually need a wheelchair or scooter for community mobility. Early, planned use prevents over-fatigue, reduces falls, and protects joints. Many people still walk short distances at home while using a wheelchair for longer trips. Mobility devices should be fitted and adjusted by a specialist team. Muscular Dystrophy Association+1

13. Workplace and school accommodations
    Simple adjustments at work or school can make a big difference: ergonomic chairs, footrests, speech-to-text software, extra time for writing tasks, or closer parking. Occupational therapists can suggest practical changes and help document needs for official accommodation forms. Charcot-Marie-Tooth Association+1

14. Mental health support and counselling
    Living with a rare, long-term nerve disease can cause sadness, anxiety, or fear about the future. Counselling and, when needed, psychiatric care can help people and families learn coping skills, manage stress, and treat depression or anxiety early. Good mental health support improves adherence to treatment and quality of life. Muscular Dystrophy Association+1

15. Podiatry and regular foot care
    Because sensation in the feet is reduced, small injuries can go unnoticed and lead to ulcers or infection. Regular visits to a podiatrist for nail care, callus removal, and shoe checks are recommended. Daily self-inspection of the feet at home is also important. Pod NMD+1

16. Energy-conservation and fatigue management
    People with CMT often tire easily because weakened muscles must work harder. Therapists teach planning (spreading heavy tasks across the day), pacing (taking short rest breaks), and prioritising (saving energy for important activities). This reduces over-fatigue and flare-ups of pain. Charcot-Marie-Tooth Association+1

17. Sleep hygiene and positioning
    Good sleep habits such as a regular bedtime, avoiding screens late at night, and keeping the room cool and dark can improve pain tolerance and daytime energy. Pillows, splints, or soft supports may be used to keep ankles, knees, or wrists in a comfortable position, reducing night cramps or tingling. Muscular Dystrophy Association+1

18. Community and peer support
    Support groups (in person or online) connect people with CMT and their families. Sharing experiences can reduce isolation and provide practical tips for dealing with mobility, school, work, and family issues. Many CMT organisations provide evidence-based educational materials reviewed by experts. Charcot-Marie-Tooth Association+1

19. Genetic counselling
    Because CMTDIF is inherited, genetic counselling helps families understand the pattern of inheritance, the risk for children, and options such as prenatal or preimplantation genetic testing. Counsellors also explain the limits of current knowledge and respect personal values and decisions. Orpha.net+1

20. Avoiding neurotoxic medicines and toxins
    Some medicines are known to harm peripheral nerves or severely worsen CMT, especially vincristine, a chemotherapy drug. People with any form of CMT should inform all their doctors about the diagnosis so they can avoid or use great caution with these drugs. Resources from patient organisations list medications that may pose extra risk in CMT. Charcot-Marie-Tooth Association+2Charcot-Marie-Tooth Disease+2

Drug treatments

Important: The medicines described here are used to manage symptoms such as neuropathic pain or mood problems. Many are not specifically approved for CMT, but for other nerve pain conditions, and may be used “off label” by specialists. Never start, stop, or change a medicine without a doctor’s advice.

1. Pregabalin (e.g., Lyrica®)
   Pregabalin is an anti-seizure medicine that also treats certain types of nerve pain. The US FDA has approved it for neuropathic pain in diabetic peripheral neuropathy, post-herpetic neuralgia, spinal cord injury, fibromyalgia, and as add-on therapy for certain seizures. FDA Access Data+1 It reduces the release of pain-signalling chemicals from nerve endings. Typical adult doses for neuropathic pain are gradually increased from about 150 mg per day to a maximum of 300–600 mg per day in divided doses, adjusted for kidney function; the exact dose and schedule must be chosen by a physician using the product label. FDA Access Data+1 Common side effects include dizziness, sleepiness, weight gain, and swelling of the legs.

2. Gabapentin (e.g., Neurontin®, Gralise®)
   Gabapentin is another anti-seizure drug widely used for nerve pain. The FDA has approved different gabapentin products for post-herpetic neuralgia and partial seizures. FDA Access Data+2FDA Access Data+2 It acts on calcium channels in nerve cells to reduce abnormal firing. For neuropathic pain, treatment is usually slowly increased over several days, often up to about 1800 mg per day (and sometimes higher) in divided doses, following the exact instructions on the chosen product label. FDA Access Data+1 Side effects may include dizziness, tiredness, and swelling.

3. Duloxetine (e.g., Cymbalta®, Drizalma Sprinkle®)
   Duloxetine is a serotonin-norepinephrine reuptake inhibitor (SNRI) antidepressant that is also approved for diabetic peripheral neuropathic pain, fibromyalgia, chronic musculoskeletal pain, and major depression. FDA Access Data+2FDA Access Data+2 It helps by increasing brain and spinal cord levels of chemicals that reduce pain signals. For neuropathic pain, the recommended adult dose is usually 60 mg once daily, sometimes starting at 30 mg daily for a week to improve tolerance, as described in FDA labels. FDA Access Data+1 Nausea, dry mouth, sleepiness, and sweating are common side effects.

4. Tricyclic antidepressants (e.g., amitriptyline)
   Amitriptyline and other tricyclic antidepressants are older depression medicines often used at low doses to treat neuropathic pain and sleep problems. They block reuptake of serotonin and norepinephrine and may directly dampen nerve pain signalling. FDA Access Data+1 They are usually taken at night in small doses at first, then cautiously increased under medical supervision. Side effects may include dry mouth, constipation, blurry vision, and drowsiness, and they must be used with special care in heart disease and in teens or young adults because of mood-related risks.

5. Topical lidocaine patches (e.g., Lidoderm®, ZTlido®, BONDLIDO™)
   Lidocaine patches deliver a local anaesthetic through the skin and are FDA-approved for pain from post-herpetic neuralgia. FDA Access Data+5FDA Access Data+5FDA Access Data+5 In some people with CMT, doctors may try them “off label” on particularly painful areas of the feet to numb the skin without strong whole-body side effects. Usual instructions limit the number of patches and hours of use per day according to each product’s label, and they must be applied only to intact skin. Skin irritation and numbness are common side effects.

6. Non-steroidal anti-inflammatory drugs (NSAIDs), such as naproxen or ibuprofen
   NSAIDs are widely used for joint and muscle pain that may occur due to abnormal walking mechanics, joint strain, or surgery. They block enzymes called COX-1 and COX-2, reducing inflammation and pain. Labels specify the maximum daily dose and timing, and they should be used at the lowest effective dose for the shortest possible time to limit risks to the stomach, kidneys, and heart.

7. Acetaminophen (paracetamol)
   Acetaminophen is often used for mild to moderate musculoskeletal pain and as part of a multi-drug pain plan. It works mainly in the brain to lower pain signalling and fever, though its exact mechanism is still not fully clear. Doses must respect the maximum daily limit stated on national and FDA labelling to avoid liver damage, especially when combined with other medicines that contain acetaminophen.

8. Opioid pain medicines (short-term, selected cases)
   In some people with severe post-operative pain or very resistant neuropathic pain, short-term or carefully supervised opioid therapy may be used. Opioids act on brain receptors to reduce pain perception but can cause dependence, constipation, drowsiness, and breathing problems. Guidelines generally recommend they be reserved for acute severe pain or carefully chosen chronic cases and always used under strict medical supervision.

9. Muscle relaxants (e.g., baclofen in selected cases)
   Spasticity (stiff, over-active muscles) is not typical of CMTDIF, but some people may have painful muscle cramps or co-existing conditions where muscle relaxants are prescribed. Baclofen acts on GABA receptors in the spinal cord to reduce muscle over-activity. Dosing is gradually increased while watching for drowsiness, dizziness, or weakness. This is specialist-prescribed and not routine for all CMT patients.

10. Antispasmodic or anti-cramp agents (e.g., quinine-free approaches)
    Because quinine-containing drugs carry important safety warnings, many clinicians avoid them for leg cramps. Instead, they may use magnesium supplements, stretching, or other prescribed medicines with safer profiles based on local guidelines. Any drug therapy for cramps must be carefully discussed with a physician, especially in people who already have nerve damage.

11. Vitamin D and calcium supplements (when deficient)
    If blood tests show Vitamin D or calcium deficiency, doctors often prescribe supplements. Vitamin D supports bone and muscle health and may reduce fracture risk in people with balance problems. Doses are based on blood levels and follow official label and guideline recommendations to avoid overdose-related toxicity.

12. B-vitamin replacement (B12, B1, B6) when low
    Some people with CMT also have separate vitamin deficiencies that worsen nerve symptoms. Correcting low B12, B1, or B6 with prescription-strength supplements may improve overall nerve function. However, excessive B6 can itself damage nerves, so dosing must follow laboratory results and medical supervision.

13. Antidepressants and anti-anxiety medicines for mood symptoms
    For depression or anxiety related to chronic illness, doctors may prescribe SSRIs, SNRIs (such as duloxetine), or other agents. These drugs adjust neurotransmitter levels in the brain to improve mood and coping. Labels include detailed information on dosing, age limits, and warnings about suicidal thoughts, especially in children and teenagers, so careful monitoring is essential. FDA Access Data+1

14. Sleep medicines (short-term use)
    Sometimes, a short course of sleep medicine is prescribed when pain or tingling makes sleep impossible. Such medicines act on brain receptors to promote sleep but can cause dependence and daytime drowsiness. Non-drug sleep strategies are usually tried first, and any sleep medicine should be closely supervised by a doctor.

15. Anti-inflammatory injections for joint issues (e.g., corticosteroid injections)
    Joint stress from abnormal walking can cause secondary problems such as bursitis or arthritis. In selected cases, a doctor may inject cortisone into a painful joint or tendon sheath. This reduces local inflammation quickly but cannot treat the underlying nerve disease and may have side effects if over-used.

16. Botulinum toxin for specific deformities (rare cases)
    In very specific patterns of muscle imbalance, specialists may inject botulinum toxin to weaken over-active muscles and improve joint position. The toxin blocks the release of acetylcholine at the neuromuscular junction. This is used cautiously and only by experienced clinicians, often as part of a plan that also includes orthoses and physiotherapy.

17. Medications for bladder or bowel problems (if present)
    Some people with peripheral neuropathy have bladder urgency or constipation. Doctors may use medicines that relax the bladder muscle or stimulate bowel movement, carefully chosen to avoid worsening dizziness or nerve symptoms. Doses and choices follow official prescribing information for each product.

18. Anti-osteoporosis drugs (if bone loss is diagnosed)
    Limited mobility can lead to bone thinning (osteoporosis). If bone density tests show high fracture risk, doctors may prescribe bisphosphonates or other anti-resorptive agents. These drugs slow bone breakdown and are taken weekly, monthly, or yearly depending on the agent, always following label instructions and with dental and kidney checks.

19. Vaccinations (e.g., flu, pneumonia, COVID-19)
    While not a “drug treatment” for CMT itself, staying up to date with vaccines can prevent infections that might worsen weakness or delay rehabilitation. Vaccine schedules follow public-health guidelines and official product information.

20. Emergency medicines for surgery and anaesthesia management
    When people with CMTDIF need surgery, anaesthetists choose medicines carefully to avoid drugs known to aggravate neuropathy or breathing. This includes adjusting doses of muscle relaxants and pain medicines and closely monitoring nerve and muscle function during the operation. Pre-operative assessment and clear communication about the CMT diagnosis are essential. Muscular Dystrophy Association+2Charcot-Marie-Tooth Association+2

Dietary molecular supplements

Evidence for supplements in CMT is limited. Most data come from general neuromuscular or neuropathy research, not specifically from CMTDIF. Always discuss supplements with a doctor to avoid side effects and interactions.

1. Omega-3 fatty acids (fish oil)
   Omega-3 fats from fish oil have anti-inflammatory and membrane-stabilising effects. They may support heart health and possibly nerve cell membranes. Typical supplemental doses in studies are often around 1–3 g per day of combined EPA and DHA, taken with food, but exact doses should follow product advice and medical guidance. Side effects may include fishy taste, loose stools, or increased bleeding risk at high doses.

2. Alpha-lipoic acid (ALA)
   ALA is an antioxidant used in some countries for diabetic neuropathy. It helps mop up free radicals and may improve blood flow to nerves. Doses in neuropathy studies commonly range around 600 mg per day, but this is not yet standard for CMT and should only be used under supervision, especially in people with thyroid or blood sugar issues.

3. Acetyl-L-carnitine
   Carnitine helps move fatty acids into mitochondria for energy. Acetyl-L-carnitine has been studied in some nerve injury and chemotherapy-induced neuropathy settings. Doses used in research often range from 500–2000 mg per day, split into several doses. Possible benefits include better energy metabolism in nerves, but evidence in CMT is still limited.

4. Coenzyme Q10 (CoQ10)
   CoQ10 is a key part of mitochondrial energy production and acts as an antioxidant. In certain mitochondrial and neuromuscular disorders, supplementation has shown benefit. Doses in studies vary from 100–300 mg per day, often taken with food for better absorption. It is usually well tolerated but can interact with blood-thinning medicines.

5. Vitamin B-complex (balanced doses)
   A balanced B-complex containing B1, B2, B6, B9, and B12 supports normal nerve function and energy metabolism. In people with borderline intake, supplementation may help overall nerve health. However, long-term high-dose B6 can damage nerves, so doses must remain within safe limits recommended by official guidelines.

6. Vitamin D (if low)
   Vitamin D supports bone, muscle, and immune health. In people with nerve disease and reduced mobility, correcting Vitamin D deficiency can reduce fall-related fracture risk and may improve muscle function. Dose depends on blood levels and national guidelines; overdose can lead to high calcium and kidney damage, so monitoring is needed.

7. Magnesium
   Magnesium is involved in muscle relaxation and nerve conduction. Some people use it for cramps or sleep problems. Typical supplemental doses are within the recommended daily allowance; higher doses can cause diarrhoea or, in kidney disease, dangerous magnesium accumulation. Only use under medical guidance.

8. Curcumin (from turmeric)
   Curcumin has anti-inflammatory and antioxidant properties and is being studied in many chronic diseases. It may help reduce inflammatory pathways that indirectly affect nerve health. Because absorption is low, many products combine curcumin with piperine or use special formulations. Doses vary widely; people on blood thinners or with gallbladder disease should be cautious.

9. Resveratrol
   Resveratrol, found in grapes and berries, has antioxidant and possible neuroprotective effects in experimental models. Human evidence is still limited, but it may support general vascular and metabolic health. As with other supplements, dose and duration must be chosen carefully to avoid interactions.

10. N-acetylcysteine (NAC)
    NAC is a precursor of glutathione, a strong antioxidant. It has been studied in some neurological conditions and may protect against oxidative stress. Typical supplemental ranges vary; high doses can cause nausea or, rarely, allergic-type reactions. Use should always be supervised by a clinician familiar with the person’s full medication list.

Regenerative, immune-modulating, and stem-cell-related approaches

There are no FDA-approved regenerative or stem-cell drugs specifically for autosomal dominant intermediate CMT type F at this time. Research is ongoing in the wider CMT and neuropathy fields. Any such treatment should only be considered in properly regulated clinical trials.

Examples of approaches under study or discussion:

1. Mesenchymal stem cell (MSC) therapies in clinical trials
   MSC therapies aim to deliver cells that release growth factors and anti-inflammatory signals to support nerve repair. Studies in other neuropathies suggest possible benefits, but safety, dosing, and long-term effects are still being investigated. At present, this should only be done in approved trials, not in commercial unregulated clinics.

2. Gene-targeted therapies and gene replacement
   Because CMTDIF is genetic, a long-term goal is to correct or silence the faulty gene. Tools like antisense oligonucleotides and viral gene delivery are being studied for some CMT types. These are still largely experimental and not available as routine treatment. Participation in clinical research, where appropriate, is the safest path.

3. Neurotrophic growth factor-based therapies
   Some experimental treatments aim to boost natural nerve growth factors or mimic their action. In animal models, these factors can promote myelin repair or axon regrowth, but translating them into safe human drugs is complex. Dosing is highly controlled in research settings.

4. Immune-modulating treatments (e.g., IVIG, steroids in misdiagnosed cases)
   Immune therapies such as intravenous immunoglobulin (IVIG) or steroids are standard for immune-mediated neuropathies (like CIDP), not for hereditary CMT. In rare cases where diagnosis is unclear, a short immune-modulating trial may be considered. Once hereditary CMTDIF is confirmed, long-term immune therapy is usually not indicated.

5. Clinical-trial medicines for neuropathic pain
   New non-opioid pain drugs are under development for neuropathic pain (for example, selective sodium-channel blockers or novel gabapentinoids). Participation in trials can provide access to cutting-edge therapies under strict safety monitoring.

6. Immune health optimisation (vaccines, infection prevention)
   While not regenerative drugs, keeping the immune system in good shape through recommended vaccines, healthy sleep, nutrition, and infection control indirectly supports nerve health and recovery from surgeries or injuries.

Surgical treatments

Surgery does not cure CMTDIF, but it can correct deformities and improve function in selected people.

1. Foot and ankle reconstructive surgery
   Long-standing muscle imbalance often leads to high-arched feet (pes cavus), clawed toes, and ankle instability. Orthopaedic surgeons may perform tendon transfers, bone cuts (osteotomies), or joint fusion (arthrodesis) to put the foot in a more stable position. The goal is to improve walking, reduce pain, and allow better use of braces. PMC+1

2. Tendon transfer procedures
   In tendon transfer surgery, a stronger muscle’s tendon is moved to take over the function of a weak muscle, such as lifting the front of the foot. This can reduce foot drop and lessen the need for heavy braces. Rehabilitation is essential after surgery to retrain muscles and protect the repair.

3. Toe correction surgery
   Hammer toes and claw toes can cause pain, corns, and difficulty wearing shoes. Surgical straightening or fusion of toe joints may be recommended when conservative measures fail. The aim is to relieve pain and improve shoe fit, not to change nerve function.

4. Spine surgery (only if structural spine problems occur)
   Most people with CMT do not need spine surgery. However, if severe scoliosis (curved spine) or spinal stenosis develops and causes pain or nerve compression, spinal surgery may be considered. Decisions are made carefully by a spine surgeon in cooperation with the neurology team.

5. Nerve decompression in superimposed entrapment neuropathy
   People with CMT can still develop carpal tunnel syndrome or other nerve compressions. In these cases, surgery to release the compressed nerve may improve symptoms like numbness or tingling in the hand. Benefits are more likely when surgery is done early and rehabilitation is provided after the procedure.

Prevention and lifestyle protection

Although the genetic cause of CMTDIF cannot be prevented, many complications can be reduced:

1. Early diagnosis and regular specialist follow-up – seeing a neurologist and rehabilitation team regularly allows early detection of deformities and timely support. Muscular Dystrophy Association+1

2. Avoiding known neurotoxic drugs (especially vincristine) – these medicines can cause severe nerve damage in people with CMT; all doctors must be informed about the diagnosis. Charcot-Marie-Tooth Association+2Charcot-Marie-Tooth Disease+2

3. Protecting feet from injury – wearing well-fitted shoes, checking feet daily, and seeing a podiatrist regularly help prevent ulcers and infections. Pod NMD+1

4. Using braces and walking aids as advised – early use of orthoses and aids can prevent falls and secondary joint damage. PMC+1

5. Maintaining a healthy body weight – extra weight puts more strain on weak muscles and joints and increases fall risk.

6. Regular gentle exercise, not over-exertion – consistent low-impact activity supports strength and heart health without over-tiring the muscles. Physiopedia+1

7. Good bone health – adequate calcium, Vitamin D, safe sun exposure, and weight-bearing exercise help limit osteoporosis and fractures.

8. Safe home environment – removing trip hazards, using grab bars and good lighting, and organising furniture for clear pathways reduce falls.

9. Smoking avoidance and minimal alcohol – both smoking and heavy alcohol use can worsen nerve damage and circulation.

10. Genetic counselling for family planning – understanding the 50% inheritance risk helps families make informed choices. Orpha.net+1

When to see doctors

You should contact a doctor – ideally a neurologist familiar with CMT – if:

• You notice new or rapidly worsening weakness, especially if you suddenly cannot lift your feet or stand as usual.

• You develop new severe pain, burning, or electric-shock sensations that do not respond to usual measures.

• You have frequent falls, serious balance problems, or new injuries.

• You find sores, ulcers, or infections on your feet that do not heal quickly.

• You see changes in the shape of your feet or toes getting worse over months.

• You develop bladder or bowel problems, such as difficulty passing urine or severe constipation.

• You experience low mood, anxiety, or thoughts of hopelessness related to the disease – mental health care is part of medical care.

• You need to start new strong medicines, especially chemotherapy or powerful antibiotics – doctors must check if they are safe for someone with CMT. Muscular Dystrophy Association+2Charcot-Marie-Tooth Association+2

Emergency medical attention is needed if you have sudden severe weakness, breathing difficulty, chest pain, or signs of serious infection (high fever, chills, spreading redness).

What to eat and what to avoid

1. Eat a balanced diet rich in fruits and vegetables – colourful plant foods provide antioxidants that support overall nerve and blood-vessel health.

2. Include lean protein – fish, poultry, beans, tofu, and eggs provide amino acids needed for muscle repair and nerve support.

3. Choose healthy fats (omega-3 and mono-unsaturated fats) – oily fish, nuts, seeds, and olive oil support heart and possibly nerve-membrane health.

4. Prefer whole grains over refined grains – whole grains give longer-lasting energy, which helps manage fatigue.

5. Stay well hydrated – adequate fluids support circulation, digestion, and muscle function.

6. Limit ultra-processed and sugary foods – high sugar and processed fats can worsen weight gain and inflammation.

7. Avoid excessive alcohol – high alcohol intake is toxic to nerves and can worsen neuropathy.

8. Avoid crash diets and extreme restrictions – these can cause nutrient deficiency, which may further harm nerves.

9. Check for and correct vitamin deficiencies – especially Vitamin D and B-vitamins under medical guidance.

10. Discuss any supplement or herbal product with your doctor – to avoid harmful interactions with prescribed medicines.

Frequently asked questions (FAQs)

1. Is autosomal dominant intermediate CMT type F curable?
   At present there is no cure for CMTDIF or other inherited CMT types. Current treatment focuses on managing symptoms, preventing deformities, and supporting independence. Research into gene and cell therapies is active, but these approaches are still experimental. ScienceDirect+2PMC+2

2. Can exercise make my nerves worse?
   Gentle, well-planned exercise is usually helpful, not harmful. Over-exertion that causes severe pain or long-lasting fatigue should be avoided. Working with a physiotherapist who understands CMT is the safest way to design a program. Physiopedia+1

3. Will I end up in a wheelchair?
   Some people with CMTDIF will need a wheelchair or scooter, at least for longer distances. Many still walk short distances. Using a wheelchair can actually increase independence and protect joints and energy rather than signal “giving up”. Muscular Dystrophy Association+1

4. Can my children get this disease?
   Because the condition is autosomal dominant, each child of an affected parent has about a 50% chance of inheriting the faulty gene. Genetic counselling can provide detailed, personalised risk information and testing options. Orpha.net+2MalaCards+2

5. Are pain medicines safe to take long-term?
   Many medicines used for neuropathic pain can be taken long-term under regular medical supervision, with careful dose adjustments to balance benefit and side effects. Opioids, in particular, must be used very cautiously. Regular follow-up with a pain specialist or neurologist is essential. FDA Access Data+2FDA Access Data+2

6. Should I avoid all chemotherapy if I have CMT?
   Not all chemotherapy is forbidden, but some drugs, especially vincristine, are known to cause severe neurotoxicity in many CMT patients and are generally avoided if possible. Oncologists and neurologists must work together to choose the safest treatment plan. Charcot-Marie-Tooth Association+2Charcot-Marie-Tooth Disease+2

7. Is it safe to get vaccinated?
   For most people with CMT, routine vaccines (such as flu, COVID-19, and pneumonia) are safe and important to prevent serious infections. Only in rare, specific situations does a neurologist advise changes to the vaccine schedule.

8. Can diet alone treat CMTDIF?
   A healthy diet supports general health and energy but cannot repair the genetic nerve damage that causes CMTDIF. Diet works best as part of a full care plan that also includes physiotherapy, orthoses, and, when needed, medicines and surgery.

9. Does CMTDIF affect life expectancy?
   Most people with CMT have a normal or near-normal life span, especially when complications such as falls, fractures, and severe infections are prevented. Quality of life can be significantly improved by active management. Muscular Dystrophy Association+1

10. Can I play sports?
    Many people with CMT can take part in low-impact sports like swimming or cycling. Contact sports or those with high fall risk (for example, rugby, skiing without support) may be less safe. A physiotherapist and doctor can help choose suitable activities.

11. Is it helpful to join a patient organisation?
    Yes. CMT organisations provide evidence-based information, specialist clinic lists, and peer support. They also help connect people to clinical trials and rehabilitation resources. Charcot-Marie-Tooth Association+1

12. Will my symptoms always get worse?
    CMTDIF is usually slowly progressive. However, the rate of change is very different from person to person. With good care, many people maintain stable function for long periods. Sudden large changes should always be evaluated by a doctor. PMC+1

13. Can children with CMTDIF attend normal school?
    Most children can attend regular school with some physical accommodations, such as extra time between classes, elevator access, or special seating. Early collaboration between parents, teachers, and therapists helps children succeed academically and socially. Muscular Dystrophy Association+1

14. Is it safe to become pregnant if I have CMTDIF?
    Many people with CMT have successful pregnancies and deliveries. However, pregnancy can temporarily worsen symptoms like balance and fatigue. Pre-pregnancy counselling with a neurologist, obstetrician, and genetic counsellor is important, and labour planning should involve the anaesthesia team. Muscular Dystrophy Association+1

15. What is the most important step I can take today?
    The most helpful first steps are to:

• Get or confirm a diagnosis with a neurologist familiar with CMT,

• Start physiotherapy and occupational therapy early, and

• Learn about braces, safe activity levels, and medicines to avoid.

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: December 24, 2025.